Elsevier

Joint Bone Spine

Volume 68, Issue 3, May 2001, Pages 231-240
Joint Bone Spine

ORIGINAL ARTICLE
EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials1

https://doi.org/10.1016/S1297-319X(01)00271-8Get rights and content

Abstract

A task force for the EULAR standing committee for clinical trials determined the methodological and logistical approach required for the development of evidence-based guidelines for treatment of knee osteoarthirits (OA). Methods. The first stage was the selection of treatment modalities to be considered. The second stage comprised a search of the databases of all European-language publications. All of the relevant studies were quality scored. The third stage involved determination of key clinical propositions by expert consensus employing a Delphi approach. The final stage involved ranking of these propositions according to the available evidence. A second set of propositions relating to a future research agenda was determined by expert consensus. Results. Seven hundred and forty-four studies presented outcome data of the effects of specific treatments on knee OA. Quantitative analysis of treatment effect was possible in only 61 studies. Recommendations for the management of knee OA based on currently available data and expert opinion are presented. Proposals for a future research agenda are highlighted. Conclusions. These are the first clinical guidelines on knee OA to combine an evidence-based approach and a consensus approach across a wide range of treatment modalities. It is apparent that only certain clinical propositions are supported by substantial research-based evidence. There is thus an urgent need for future well-designed trials to address key clinical questions.

Section snippets

Recommendations …

Clinical guidelines were defined by the Institute of Medicine in Washington 〚1〛 as “Systematically developed statements to assist practitioner and patient decisions about appropriate healthcare for specific clinical conditions.” These recommendations appeared about 10 years ago (more than 230 papers on Medline for the January-November 2000 period only). In France, ANAES (Agence Nationale dˈAccréditation et dˈEvaluation en Santé: National Agency for Health Assessment and Accreditation) regularly

…in osteoarthritis

Osteoarthritis (OA) is by far the most common disease to affect synovial joints. It is a major cause of pain and disability. Its cost – estimated in France at more than 6 billion francs in 1993 〚2〛 – poses a community health care problem. With the increasing proportion of elderly people in the population, OA will become an even more important challenge.

OA of the knees is particularly common, with radiographic OA of the tibio-femoral compartment occurring in 5 to 15% of persons aged 35–74 years.

The task force

A task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutic Trials was created in September 1998. It involved a committee of 21 experts in the field of osteoarthritis (rheumatologists and orthopaedic surgeons) representing 13 different European countries together with two experts in the field of guidelines methodology and one pharmacologist (table I).

The objectives of the Committee were: 1) to describe the therapies available for the treatment of knee

Methods

The first step was to produce a comprehensive list of treatment modalities to be included in the review process.

The second step was a systematic search conducted using two databases, Medline Ovid and Bids Embase. All European-language publications in the form of clinical trials and meta-analyses were included. The searches were conducted for the period January–December 1966-1998 and were last performed in July 1999. The methodological quality of each study was scored (from 0 to 28) according to

The list of the 23 treatment modalities

Ten of these modalities are non-pharmacological, nine concern pharmacological tools and four are surgical procedures. Topical (percutaneous) therapy includes NSAIDs and capsaicine or other local analgesics not marketed in France. Vitamins and mineral salts are grouped as ‘nutrients’ (table IV).

Evidence-based approach

Two thousand eight hundred and ninety-two studies were identified by the search strategy; 744 were intervention trials involving knee osteoarthritis. Six hundred and eighty of these trials involved at

Discussion

These are the first clinical guidelines on knee OA to be developed by EULAR. An evidence-based approach was specifically chosen by the Task Force. This was to minimise the potential limitations of ‘expert opinion’ alone 〚50〛 and to permit, wherever possible, calculation of effect sizes and NNT to allow comparison of efficacy between diverse forms of treatment.

Despite the strengths of this method of guideline development a number of caveats deserve emphasis. Although we employed a traditional

References (51)

  • M.J Field et al.

    Clinical practice guidelines: directions for a new program

    (1990)
  • E Levy et al.

    Les coûts socio-économiques de l'arthrose en France

    Rev Rhum 〚Éd Fr〛

    (1993)
  • M.C Hochberg et al.

    Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee

    Arthritis Rheum

    (1995)
  • D.L Scott

    Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians

    J R Coll Physicians London

    (1993)
  • S.H Downs et al.

    The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and non-randomized studies of health care interventions

    J Epidemiol Community Health

    (1998)
  • J Cohen

    Statistical power analysis for the behavioral sciences

    New York: N Y Acad Press

    (1977)
  • A Laupacis et al.

    An assessment of clinically useful measures of the consequences of treatment

    N Engl J M

    (1988)
  • M Eccles et al.

    North of England Evidence Based Guidelines Development Project: methods of developing guidelines for efficient drug use in primary care

    BMJ

    (1998)
  • C.L Deal et al.

    Treatment of arthritis with topical capsaicin: a double-blind trial

    Clin Ther

    (1991)
  • R.L Dreiser et al.

    DHEP plasters as a topical treatment of knee osteoarthritis. A double-blind placebo-controlled study

    Drugs Exp Clin Res

    (1993)
  • G Kolarz et al.

    Hyaluronic acid in the treatment of osteoarthritis of the knee joint: interim results of a comparative clinical study

    Eur J Rheumatol Inflamm

    (1995)
  • P Lee et al.

    The efficacy of diflunisal in osteoarthritis of the knee. A Canadian Multicenter Study

    J Rheumatol

    (1985)
  • P Ravaud et al.

    Effects of joint lavage and steroid injection in patients with osteoarthritis of the knee: results of a multicenter, randomized, controlled trial

    Arthritis Rheum

    (1998)
  • S.C O'Reilly et al.

    Effectiveness of home exercise on pain and disability from osteoarthritis of the knee: a randomized controlled trial

    Annal Rheum Dis

    (1997)
  • W.H Ettinger et al.

    A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis

    The Fitness Arthritis and Seniors Trial (FAST). JAMA

    (1997)
  • Cited by (47)

    • Long-term use of minimal footwear on pain, self-reported function, analgesic intake, and joint loading in elderly women with knee osteoarthritis: A randomized controlled trial

      2015, Clinical Biomechanics
      Citation Excerpt :

      On the other hand, analgesic intake in the intervention group remained unchanged after the third month, and significantly lower than controls. This is a satisfactory result, since the European League Against Rheumatism (Mazieres et al., 2001) considers that reduction of this type of medication has health benefits in OA treatment. Throughout the six months, the increased paracetamol intake by the control group compared to the intervention group can be explained by a possible pain increased caused by the increasing of 15.4% in KAM peak suffered only by the group which did not wear the Moleca® footwear (within-group).

    • Systematic review of guidelines for the physical management of osteoarthritis

      2014, Archives of Physical Medicine and Rehabilitation
      Citation Excerpt :

      Six guidelines can be recommended without modifications.14,17,20,24-26 Eleven guidelines1,5,18,19,21-23,27-30 were recommended with modifications. Forty interventions were identified across the guidelines.

    View all citing articles on Scopus
    1

    This paper is a short and commented version of the article from Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis. Ann Rheum Dis 2000 : 59 : 936-44.

    View full text